glp 1 eye problems Danny D. | ๐๏ธ Important safety update from the *BMJ*: Emerging evidence and regulatory reviews are prompting new warnings about a potential link GLP-1 drugs are associated with
Description
For the CagriSema combination, gastrointestinal adverse events affected 79.6% of participants compared to 39.9% with placebo
Therefore, proactive planning remains a cornerstone of care
The app allows you to message a healthcare professional to discuss your progress and adjust your plan as needed
Accessed April 10, 2026
As prescriptions for these agents soar, recognizing these atypical adverse effects is crucial for proper patient management
Ann Pharmacother 2012
